C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.060
-0.120 (-3.77%)
At close: Oct 23, 2026, 4:00 PM EDT
3.090
+0.030 (0.98%)
Pre-market: Oct 26, 2026, 5:01 AM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $376.46 million as of October 23, 2026. It is the 16,556th most valuable company in the world and the 2,955th biggest in the United States. Its market cap has increased by 77.41% in one year.
Market Cap
376.46M
Enterprise Value
132.87M
1-Year Change
77.41%
Global Rank
Country Rank
#2,955 United States
Category
ChartMarket Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $376.46M, a decrease of -51.28%. That is a compound annual growth rate of -11.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 376.46M | 103.37% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 406.47M |
| ARS Pharmaceuticals | 403.26M |
| Assembly Biosciences | 403.14M |
| Nautilus Biotechnology | 397.04M |
| Eikon Therapeutics | 395.95M |
| Tectonic Therapeutic | 392.16M |
| Prelude Therapeutics | 376.96M |
| TRex Bio | 375.29M |